KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Assets Average (2016 - 2025)

Gilead Sciences (GILD) has disclosed Assets Average for 17 consecutive years, with $58.8 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average changed N/A year-over-year to $58.8 billion, compared with a TTM value of $58.8 billion through Dec 2025, changed N/A, and an annual FY2025 reading of $59.0 billion, down 2.56% over the prior year.
  • Assets Average was $58.8 billion for Q4 2025 at Gilead Sciences, up from $54.9 billion in the prior quarter.
  • Across five years, Assets Average topped out at $67.9 billion in Q1 2021 and bottomed at $54.9 billion in Q2 2024.
  • Average Assets Average over 5 years is $63.0 billion, with a median of $62.5 billion recorded in 2023.
  • The sharpest move saw Assets Average increased 17.12% in 2021, then decreased 11.55% in 2024.
  • Year by year, Assets Average stood at $67.5 billion in 2021, then fell by 6.9% to $62.9 billion in 2022, then fell by 0.98% to $62.2 billion in 2023, then fell by 11.75% to $54.9 billion in 2024, then grew by 6.99% to $58.8 billion in 2025.
  • Business Quant data shows Assets Average for GILD at $58.8 billion in Q4 2025, $54.9 billion in Q2 2024, and $59.2 billion in Q1 2024.